March 17 (Reuters) - HCW Biologics Inc HCWB.O:
HCW BIOLOGICS CLOSES EXCLUSIVE WORLDWIDE LICENSE FOR HCW11-006 – A HIGH POTENTIAL FUSION IMMUNOTHERAPEUTIC
HCW BIOLOGICS INC - RECEIVES $7.0 MILLION UPFRONT LICENSE FEE FROM BEIJING TRIMMUNE BIOTECH
HCW BIOLOGICS INC - HAS FREE OPTION TO RECLAIM AMERICAS RIGHTS